Clinical Trial Update: Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial update for an Ebola Sudan chimpanzee adenovirus vector vaccine in healthy adults; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Virus | Phase 1 | Status: COMPLETED | Results posted: 2021-11-24